| 26.19 -1.82 (-6.5%) | 06-05 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 35.48 | 1-year : | 41.45 |
| Resists | First : | 30.38 | Second : | 35.48 |
| Pivot price | 25.2 |
|||
| Supports | First : | 24.91 | Second : | 21.53 |
| MAs | MA(5) : | 27.39 |
MA(20) : | 25.44 |
| MA(100) : | 23.65 |
MA(250) : | 37.68 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 73.8 |
D(3) : | 79.8 |
| RSI | RSI(14): 51.9 |
|||
| 52-week | High : | 70.43 | Low : | 13.73 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ HIMS ] has closed below upper band by 37.0%. Bollinger Bands are 24% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.92 - 28.07 | 28.07 - 28.19 |
| Low: | 25.07 - 25.23 | 25.23 - 25.36 |
| Close: | 25.93 - 26.2 | 26.2 - 26.43 |
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Sat, 06 Jun 2026
Hims & Hers Names Dr. Anant Vinjamoori Chief Medical Officer Of Hims - Pulse 2.0
Sat, 06 Jun 2026
Hims & Hers Completes Eucalyptus Acquisition And Expands Weight Management Care In Germany - Pulse 2.0
Sat, 06 Jun 2026
Hims & Hers Health Options Spot-On: On June 3rd, 96,548 Contracts Were Traded, With 1.06 Million Open Interest - Moomoo
Fri, 05 Jun 2026
How Investors Are Reacting To Hims & Hers Health (HIMS) Hiring a Longevity-Focused Chief Medical Officer - simplywall.st
Fri, 05 Jun 2026
Hims CMO Appointment Highlights Longevity Focus And Raises Valuation Questions - Yahoo Finance
Thu, 04 Jun 2026
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 223 (M) |
| Shares Float | 211 (M) |
| Held by Insiders | 5.4 (%) |
| Held by Institutions | 69.9 (%) |
| Shares Short | 63,370 (K) |
| Shares Short P.Month | 69,770 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.92 |
| Profit Margin | -0.6 % |
| Operating Margin | -8 % |
| Return on Assets (ttm) | 0.6 % |
| Return on Equity (ttm) | -2.7 % |
| Qtrly Rev. Growth | 3.7 % |
| Gross Profit (p.s.) | 7.75 |
| Sales Per Share | 10.62 |
| EBITDA (p.s.) | 0.37 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 280 (M) |
| Levered Free Cash Flow | 174 (M) |
| PE Ratio | -291 |
| PEG Ratio | 2.1 |
| Price to Book value | 13.56 |
| Price to Sales | 2.46 |
| Price to Cash Flow | 20.84 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|